Results 171 to 180 of about 760,147 (214)
Some of the next articles are maybe not open access.

Regulatory Aspects of Microdialysis: A United States Food and Drug Administration Perspective

2012
The purpose of this chapter is to illustrate the potential applications of microdialysis (MD) in drug discovery and development with the aim of meeting Food and Drug Administration (FDA) requirements for evaluating drug bioavailability (BA) and/or establishing bioequivalence (BE).
Chinmay Shukla   +3 more
openaire   +1 more source

Incentivizing Orphan Product Development: United States Food and Drug Administration Orphan Incentive Programs

2017
Over 30 years ago, the United States (US) Congress passed the Orphan Drug Act (ODA) to encourage the development of products for rare diseases or conditions ("orphan products"). The Act provided incentives to sponsors for developing products with orphan designation and established a grant program to fund studies of orphan products.
openaire   +2 more sources

New cancer breakthrough therapies at the United States Food and Drug Administration

Journal of Hospital Management and Health Policy, 2018
Cancer is an emotive word that strikes fear into many people. This is hardly surprising since premature death due to cancer is the leading cause of mortality in Canada, the United States and many other countries.
openaire   +1 more source

United States Food and Drug Administration requirements for approval of generic drug products.

The Journal of clinical psychiatry, 2001
As generic products become more available for the treatment of psychiatric disorders, clinicians must stay abreast of the U.S. Food and Drug Administration (FDA) requirements for the approval of generic drug products. The FDA declares that pharmaceutical equivalents only are therapeutically equivalent, and pharmacokinetic data are all that is usually ...
openaire   +1 more source

Nonclinical Development of Radiopharmaceuticals: Regulatory Considerations for the United States Food and Drug Administration

2004
In general, the nonclinical studies conducted to support the development of radiopharmaceuticals should be consistent with current International Conference on Harmonization (ICH) Guidelines. The United States Food and Drug Administration (FDA), however, has recognized that certain characteristics of radiopharmaceuticals necessitate an adaptation of the
openaire   +2 more sources

Women in Clinical Drug Trials: United States Food and Drug Administration Update on Policies and Practices

2012
It is now well established that subgroup populations deserve a careful assessment of their response differences in order to derive maximum benefit from medical products, and that the concept of ‘one ...
openaire   +1 more source

Data from the United States Food and Drug Administration

JAIDS Journal of Acquired Immune Deficiency Syndromes, 2005
openaire   +2 more sources

The United States Food and Drug Administration and the practice of optometry.

Journal of the American Optometric Association, 1979
In the past decade the United States Food and Drug Administration has become increasingly involved with the regulation of materials used in the practice of optometry. It is the purpose of this paper to help the practitioner understand the FDA involvement, historically and legally, organization, how one can have input into the process, the procedures ...
openaire   +1 more source

Home - About - Disclaimer - Privacy